|Free Dividend Report|
|ABBV Dividend History|
|ABBV Historical Stock Prices|
|Preferred Stock Newsletter|
|ABBV Options Chain|
|ABBV Message Board|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on November 22, 2023, ABBV opened at $139.06, traded as high as $139.84 and as low as $138.33, and closed at $138.47. Trading volume was a total of 3.43M shares. On November 24, 2023, ABBV opened at $140.00, traded as high as $140.08 and as low as $138.46, and closed at $138.67. Trading volume was a total of 1.64M shares. On November 27, 2023, ABBV opened at $138.70, traded as high as $139.38 and as low as $137.79, and closed at $139.09. Trading volume was a total of 5.53M shares. On November 28, 2023, ABBV opened at $139.05, traded as high as $139.66 and as low as $137.92, and closed at $138.08. Trading volume was a total of 5.35M shares. On November 29, 2023, ABBV opened at $138.02, traded as high as $139.09 and as low as $137.65, and closed at $138.50. Trading volume was a total of 4.00M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|Average Annual Total Return:||15.39%|
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||13.45%|
|ABBV Historical Price Range|
|AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid.|
|ABBV Historical Closing Prices|
|Healthcare Historical Prices|
|ABBV is categorized under the Healthcare sector; below are some other companies in the same sector:
ABC Historical Stock Prices
Also explore: ABBV shares outstanding history
ABBV Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights ReservedNothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.